Trypanosoma cruzi genetic diversity: Something new for something known about Chagas disease manifestations, serodiagnosis and drug sensitivity

B Zingales - Acta tropica, 2018 - Elsevier
The genetic diversity of Trypanosoma cruzi, the protozoan agent of Chagas disease, is
widely recognized. At present, T. cruzi is partitioned into seven discrete typing units (DTUs) …

[HTML][HTML] Pathogen diversity, immunity, and the fate of infections: lessons learned from Trypanosoma cruzi human–host interactions

LMD Magalhães, KJ Gollob, B Zingales… - The Lancet …, 2022 - thelancet.com
The complexity of host–pathogen interactions often leads to distinct clinical outcomes upon
infection with different pathogen strains. In this Review, we explore the interactions between …

[HTML][HTML] Adrenergic signaling in muscularis macrophages limits infection-induced neuronal loss

F Matheis, PA Muller, CL Graves, I Gabanyi, ZJ Kerner… - Cell, 2020 - cell.com
Enteric-associated neurons (EANs) are closely associated with immune cells and
continuously monitor and modulate homeostatic intestinal functions, including motility and …

[HTML][HTML] Acute Chagas disease: new global challenges for an old neglected disease

DV Andrade, KJ Gollob, WO Dutra - PLoS neglected tropical …, 2014 - journals.plos.org
Chagas disease is caused by infection with the protozoan Trypanosoma cruzi, and although
over 100 years have passed since the discovery of Chagas disease, it still presents an …

[HTML][HTML] Current understanding of immunity to Trypanosoma cruzi infection and pathogenesis of Chagas disease

FS Machado, WO Dutra, L Esper, KJ Gollob… - Seminars in …, 2012 - Springer
Chagas disease caused by Trypanosoma cruzi remains an important neglected tropical
disease and a cause of significant morbidity and mortality. No longer confined to endemic …

[HTML][HTML] A Review on the Immunological Response against Trypanosoma cruzi

G Macaluso, F Grippi, S Di Bella, V Blanda, F Gucciardi… - Pathogens, 2023 - mdpi.com
Chagas disease is a chronic systemic infection transmitted by Trypanosoma cruzi. Its life
cycle consists of different stages in vector insects and host mammals. Trypanosoma cruzi …

[HTML][HTML] Biomarkers of therapeutic responses in chronic Chagas disease: state of the art and future perspectives

MJ Pinazo, MC Thomas, J Bustamante… - Memórias do Instituto …, 2015 - SciELO Brasil
The definition of a biomarker provided by the World Health Organization is any substance,
structure, or process that can be measured in the body, or its products and influence, or …

[HTML][HTML] CD8+ T-Cells Expressing Interferon Gamma or Perforin Play Antagonistic Roles in Heart Injury in Experimental Trypanosoma Cruzi-Elicited Cardiomyopathy

JC Silverio, IR Pereira, MC Cipitelli, NF Vinagre… - PLoS …, 2012 - journals.plos.org
In Chagas disease, CD8+ T-cells are critical for the control of Trypanosoma cruzi during
acute infection. Conversely, CD8+ T-cell accumulation in the myocardium during chronic …

[HTML][HTML] Fifteen Years after the Definition of Trypanosoma cruzi DTUs: What Have We Learned?

B Zingales, AM Macedo - Life, 2023 - mdpi.com
Trypanosoma cruzi, the protozoan causative of Chagas disease (ChD), exhibits striking
genetic and phenotypic intraspecific diversity, along with ecoepidemiological complexity …

High interleukin 17 expression is correlated with better cardiac function in human Chagas disease

LMD Magalhães, FNA Villani… - The Journal of …, 2013 - academic.oup.com
This study was designed to investigate whether the expression of interleukin 17 (IL-17) is
associated with the indeterminate or cardiac clinical forms of Chagas disease and whether …